Firma Lonza Group Ltd., Autor bei PR-Web

Lonza’s Pharma Biotech Business Drives Strong H1 2020 Group Sales Growth and Margin Improvement

Posted on 24. July 2020 by Firma Lonza Group Ltd. Posted in General Tagged cell, coatings, ebitda, flat, lonza, lpbn, lsi, market, mrna, securities, statements, vaccine, vaccines, vitamin, with

Strong operational performance maintained during COVID-19; sites remained open and protection of employees continues to be a top priority Landmark ten-year collaboration with Moderna on the mRNA1 platform. The current focus is to manufacture an mRNA-based vaccine (mRNA-1273) for the novel […]

Sven Abend Leaves Lonza to Take CEO Position in Germany

Posted on 30. June 2020 by Firma Lonza Group Ltd. Posted in General Tagged any, business, clarity, covid, disinfection, ingredients, lonza, lsi, may, risks, securities, solutions, statements, swiss, trading

• Sven Abend has decided to resign from Lonza to take a CEO position in Germany. • Recruitment plans are under way to appoint a permanent replacement. • LSI is performing well and the segment carve-out process is nearing completion. […]

Lonza Appoints New Chief Executive Officer

Posted on 5. June 2020 by Firma Lonza Group Ltd. Posted in General Tagged board, company, customers, interim, lonza, lonzas, novartis, prior, risks, roche, securities, statements, strong, swiss, trading

The Board of Lonza announced today that Pierre-Alain Ruffieux has been appointed Chief Executive Officer effective 1 November 2020. Pierre-Alain is currently Head of Global Pharma Technical Operations at Roche where he and his 12,000-strong team are responsible for […]

Moncef Slaoui to Step Down as Member of the Board of Directors of Lonza Group

Posted on 18. May 2020 by Firma Lonza Group Ltd. Posted in General Tagged advisor, board, chief, directors, down, lonza, member, national, new, program, slaoui, speed, step, vaccine, warp

Dr Moncef Slaoui has decided to step down from his position as a member of the Lonza Group Board of Directors, following his appointment to the role of Chief Advisor for the U.S. government’s “Warp Speed” national vaccine program. Lonza […]